Although systemic vasculitis can be a complication of inflammatory bowel disease at several locations (skin, eyes, brain, mesentery, and lung) the association of retinal vasculitis with Crohn's disease is rare. We studied a 26-year-old woman with biopsy-demonstrated Crohn's disease who developed a severe bilateral retinal arteritis and phlebitis, with acute loss of vision.
Introduction Ocular disorders arising in association with
Crohn's disease occur in between 4 and 6% of cases (see box).'-4 Retinal vasculitis, however, is an uncommon complication.5`7 There has often been an association found between some of the systemic complications of Crohn's disease.'
The pathogenic mechanism of retinal injury could be either vasculitis ofvessels5-7 or thrombotic occlusion of vessels."4'8 Fluorescein angiography study is useful in diagnosis of retinal vasculitis.57
Case report A 26-year-old woman with a seven-year history of Crohn's disease was admitted to the hospital after five months of lower left quadrant abdominal pain associated with diarrhoea with blood, vomiting, fever, and weight loss. Her temperature at admission was 37.2°C.
Initial investigations are shown in the box. A barium enema showed edema, ulceration, mucosal thickening and fistulas penetrating to the vagina. Flexible colonoscopy demonstrated a segmental colitis with rectal and sigmoid involvement. The patient had biopsy-proven Crohn's disease. Treatment (6-methylprednisolone, 1 mg/kg/day, and parenteral nutrition) resulted in clinical and analytical improvement.
Despite the clinical and analytical improvement, the patient began to suffer an acute loss of vision. On examination, the visual acuity was found to be: right eye 0.1, left eye 0.6. The intraocular pressures were: right eye 13 Intravenous fluorescein angiography showed prolongation of the arm-retinal transit time with swollen optic disks which demonstrated diffuse leakage of fluorescein. It also showed neovascularisation filling and intraretinal haemorrhage on the posterior pole (figure 2).
Cyclophosphamide (100 mg/day) and prednisone (50 mg/day) was employed but only improvement of the uveitis and vitritis was observed. The retinal vasculitis did not improve.
Six weeks later, she could only count fingers at most 3 m with the right eye. The visual acuity of the left eye remained unchanged. In Crohn's disease and in ulcerative colitis, the vasculitis could affect several tissues (retina,`7 skin,9 brain,'0 bowel,'""3 lung'2). A possible pathogenic mechanism in Crohn's disease could be inflammatory microvascular occlusion, associated with vasculitis. In the affected bowel, the injury is focal and it may occur in the absence of either macroscopic or microscopic disease." The pathogenic sequence ofevents in Crohn's disease might be: vascular injury, focal arteritis, fibrin deposition and arterial occlusion followed by tissue infarction or neovascularisation.""',3 Granulomatous vasculitis was suggested to be the mechanism of tissue injury"3: granulomatous inflammation was associated with focal disruption of the blood vessel walls, adherence of chronic inflammatory cells to the luminal surface of the lesion, and fibrin deposition. This pathogenic sequence was only seen in specimens from small and large bowel Crohn's disease."3 However, this granulomatous inflammation has not been observed in other tissues, although immunochemical staining techniques were not used to identify vascular structures and granulomas in these studies.9'l2
Retinal vasculitis is uncommon in Grohn's disease, although there are some systemic diseases (sarcoidosis, tuberculosis, syphilis, toxoplasmosis, cytomegalovirus, herpes zoster, temporal arteritis, polyarteritis nodosum, systemic lupus erythematosus and multiple sclerosis) which can be associated with retinal vasculitis, and there is also an idiopathic presentation (Eale's disease).'4 These other systemic diseases were rejected on the basis of negative results in their differential diagnosis. Retinal arterial occlusions have been described in previous reports of patients with Crohn's disease, but the authors saw no evidence of intrinsic retinal vascular disease in the fluorescein angiography and the aetiology of these lesions was thrombi occluding small vessels."4 In our patient, the absence of any previous systemic manifestation of thromboembolic phenomena, and the normal coagulation studies and platelet count when the acute loss of vision began did not suggest a thromboembolic phenomenon. Moreover, the fluorescein angiography of our patient demonstrated retinal vasculitis.
In our patient, the inflammatory bowel disease complication manifested as acute loss of vision due to severe, bilateral, obliterative and proliferative retinal vasculitis in which the arteries were predominantly affected. We observed cotton-wool spots in her eyes suggesting tissue ischaemia, leakage of fluorescein indicating haemorrhage, and neovascularisation (figures 1 and 2) .
There are other previously reported cases that share some similarities with our case.5~7
Two involved patients with Crohn's disease who have optic nerve vasculitis with secondary involvement of retinal vessels,6~7 and another was of a patient with arterial and venous vasculitis.5 Papillitis, haemorrhages and sheathing of vessels was observed in these patients.57
The treatments employed in these previous reports have been prednisone or cyclophosphamide plus corticosteroids. The improvement of the ocular damage was limited.57 In our case, we used cyclophosphamide plus prednisone, but only the uveitis and vitritis improved. The retinal vessel lesions did not improve. 
